D. Western Therapeutics Institute, Inc. (TYO:4576)
126.00
-2.00 (-1.56%)
Jun 13, 2025, 3:30 PM JST
TYO:4576 Revenue
D. Western Therapeutics Institute had revenue of 96.76M JPY in the quarter ending March 31, 2025, a decrease of -6.96%. This brings the company's revenue in the last twelve months to 463.52M, up 4.87% year-over-year. In the year 2024, D. Western Therapeutics Institute had annual revenue of 471.00M with 10.05% growth.
Revenue (ttm)
463.52M
Revenue Growth
+4.87%
P/S Ratio
12.31
Revenue / Employee
22.07M
Employees
21
Market Cap
5.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 471.00M | 43.00M | 10.05% |
Dec 31, 2023 | 428.00M | -20.00M | -4.46% |
Dec 31, 2022 | 448.00M | 34.00M | 8.21% |
Dec 31, 2021 | 414.00M | 59.00M | 16.62% |
Dec 31, 2020 | 355.00M | -225.00M | -38.79% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |